封面
市場調查報告書
商品編碼
1457968

自我血糖測量設備的全球市場:市場規模和佔有率分析(依類型、應用和最終用戶)、工業需求預測(截至 2030 年)

Self-Monitoring Blood Glucose Devices Market Size and Share Analysis by Type, Application, End User - Global Industry Demand Forecast to 2030

出版日期: | 出版商: Prescient & Strategic Intelligence | 英文 270 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年全球自我監測血糖 (SMBG) 設備市場規模將達到 253 億美元。 預計2024年至2030年複合年增長率為9.7%,最終在2030年達到482億美元。

該行業的發展受到糖尿病增加、老年人口增加、技術進步、糖尿病治療意識增強以及肥胖人口增加等因素的推動。 此外,英國、美國、義大利、德國、法國、日本、西班牙等國家的SMBG設備報銷指南也是推動產業發展的另一個重要原因。

測試條仍是銷售量最大的設備類型

依類型劃分,試紙的銷售佔有率最高,2023 年將達 40%。 此類試紙由一次性塑膠製成,充滿葡萄糖氧化物,有助於檢查血糖水平。 這些有利的葡萄糖測試條也可用於檢查血液中的酮含量。

由於老年人和肥胖人口的增加,糖尿病發生率增加

世界老年人口正快速成長。

預計 65 歲及以上老年人口比例將從 2022 年的 10% 迅速增加到 2050 年的 16%,凸顯了人口結構的重大變化。

這種老化趨勢將成為SMBG裝備產業發展的巨大動力。

北美引領市場

2023年,北美地區佔比最大,達55%。

這一比例極高的原因是高血糖發病率不斷上升、老年人口不斷增加,以及高血糖在北美已成為一種與生活方式相關的重要疾病。

技術進步和創新產品的定期推出也有助於非洲大陸產業的發展。

本報告分析了全球自我血糖監測(SMBG)設備市場,並提供了有關市場的基本結構和最新情況、主要促進和抑制因素以及全球、依地區和主要市場規模趨勢的資訊。前景(基於數量/價值,2017-2030 年)、依類型、應用和最終用戶劃分的詳細趨勢、市場競爭的現狀以及主要公司的概況。

目錄

第一章研究範圍

第二章研究方法

第 3 章執行摘要

第 4 章市場指標

第五章產業展望

  • 市場動態
    • 趨勢
    • 促進因素
    • 抑制因素/課題
    • 促進/抑制因子影響分析
  • 新型冠狀病毒感染 (COVID-19) 的影響
  • 波特五力分析

第六章世界市場

  • 摘要
  • 市場規模:依類型劃分(2017-2030 年)
  • 市場收入:依類型劃分(2017-2030 年)
  • 市場規模:依應用劃分(2017-2030 年)
  • 市場收入:依應用分類(2017-2030 年)
  • 市場規模:依最終用戶劃分(2017-2030 年)
  • 市場收入:以最終用戶劃分(2017-2030 年)
  • 市場規模:依地區劃分(2017-2030 年)
  • 市場收入:依地區劃分(2017-2030 年)

第七章北美市場

  • 摘要
  • 市場規模:依類型劃分(2017-2030 年)
  • 市場收入:依類型劃分(2017-2030 年)
  • 市場規模:依應用劃分(2017-2030 年)
  • 市場收入:依應用分類(2017-2030 年)
  • 市場規模:依最終用戶劃分(2017-2030 年)
  • 市場收入:以最終用戶劃分(2017-2030 年)
  • 市場規模:依國家劃分(2017-2030 年)
  • 市場收入:依國家/地區劃分(2017-2030 年)

第8章歐洲市場

第9章亞太市場

第10章拉丁美洲市場

第 11 章中東與非洲 (MEA) 市場

第12章美國市場

  • 摘要
  • 市場規模:依類型劃分(2017-2030 年)
  • 市場收入:依類型劃分(2017-2030 年)
  • 市場規模:依應用劃分(2017-2030 年)
  • 市場收入:依應用分類(2017-2030 年)
  • 市場規模:依最終用戶劃分(2017-2030 年)
  • 市場收入:以最終用戶劃分(2017-2030 年)

第十三章加拿大市場

第14章德國市場

第十五章法國市場

第十六章英國市場

第十七章義大利市場

第十八章西班牙市場

第十九章日本市場

第20章中國市場

第21章印度市場

第22章澳洲市場

第23章韓國市場

第24章巴西市場

第25章墨西哥市場

第26章沙烏地阿拉伯市場

第27章南非市場

第 28 章阿聯酋 (UAE) 市場

第29章競爭態勢

  • 市場參與者及其提供的產品/服務的列表
  • 主要公司的競爭基準
  • 各大公司的產品基準
  • 近期策略發展狀況

第30章公司簡介

  • Johnson & Johnson Services Inc.
  • ARKRAY Inc.
  • Nova Biomedical
  • Bionime Corporation
  • Medtronic plc
  • B. Braun Melsungen AG
  • Abbott Laboratories
  • Bayer AG

第31章附錄

簡介目錄
Product Code: 10484

In 2023, the worldwide self-monitoring blood glucose devices market accrued revenue of

USD 25.3 billion. It is anticipated to grow at a compound annual growth rate (CAGR) of 9.7% between 2024 and 2030, ultimately reaching USD 48.2 billion by 2030.

This development of the industry is credited to the growing occurrence of diabetes, the rising populace of elderly people, technical improvements, thriving awareness of diabetes care, increasing count of obese populations, and the compensation guidelines for SMBG devices in several nations, such as the U.K., the U.S., Italy, Germany, France, Japan, and Spain, are another significant reason propelling the industry development.

Market Trends

Technical Improvements in SMBG Devices: The worldwide SMBG industry is experiencing a trend of constant technical improvements in SMBG devices. Such innovations comprise the development of new-age instruments that significantly decrease the time taken to test sugar levels compared to traditional lab approaches.

Portability and Convenience: A major trend in the self-monitoring blood glucose devices market is the focus on portability and suitability. Several SMBG devices are made to be compact and simple to carry, offering users better flexibility and convenience in monitoring their blood glucose levels.

Smartphone Integration and Mobile Apps: Another notable trend is the integration of SMBG devices with smartphones and the widespread use of mobile apps. Smartphone apps are playing a crucial role in helping patients manage hyperglycemia by providing education on the condition, promoting healthy lifestyle choices, offering tools for tracking sugar levels, and facilitating medication adherence.

Mobile Sugar Checkers: Companies are increasingly introducing mobile sugar checkers that can be connected to smartphones. These devices allow users to monitor their sugar levels on the go and conveniently access their data through mobile apps, contributing to better management of diabetes and hyperglycemia.

Test Strips Remain the Top-Selling Device Type

In 2023, on the basis of type, the sale of strips had the largest share of 40%. Such strips are manufactured from disposable plastic and saturated with glucose oxides, which aid in checking the sugar level. These lucrative glucose measuring strips can also be utilized for checking the ketone level in the blood.

Increasing Diabetes Frequency with Thriving Elderly and Obese Populations

The worldwide elderly populace is witnessing quick development, as shown by the world population prospects report from the UN.

The share of people elderly 65 years or older is estimated to surge from 10% in 2022 to 16% by 2050, highlighting a substantial demographic shift.

This elderly trend is a major propeller for the development of the self-measuring blood glucose devices industry.

Elderly people are more vulnerable to diabetes in comparison to younger demographics, leading to an augmented need for blood glucose tracking devices between this age group.

North Americans Lead in Diabetes Self-Monitoring and Management

In 2023, the North American region held the largest share, 55%, of the industry.

This dominating regional position can be credited to the increasing occurrence of hyperglycemia and a rising elderly populace, making hyperglycemia a substantial lifestyle disease in North America.

Technical improvements and regular launches of innovative items are contributing to industry development in the continent.

Competition Analysis

For example, in 2022, Dexcom Inc. got FDA clearance for Dexcom G7 for all kinds of hyperglycemic patients ages two years and more in the U.S.

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by type
    • 1.4.2. Market size breakdown, by application
    • 1.4.3. Market size breakdown, by end user
    • 1.4.4. Market size breakdown, by region
    • 1.4.5. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Volume
    • 1.5.2. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Volume, by Type (2017-2030)
  • 6.3. Market Revenue, by Type (2017-2030)
  • 6.4. Market Volume, by Application (2017-2030)
  • 6.5. Market Revenue, by Application (2017-2030)
  • 6.6. Market Volume, by End User (2017-2030)
  • 6.7. Market Revenue, by End User (2017-2030)
  • 6.8. Market Volume, by Region (2017-2030)
  • 6.9. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Volume, by Type (2017-2030)
  • 7.3. Market Revenue, by Type (2017-2030)
  • 7.4. Market Volume, by Application (2017-2030)
  • 7.5. Market Revenue, by Application (2017-2030)
  • 7.6. Market Volume, by End User (2017-2030)
  • 7.7. Market Revenue, by End User (2017-2030)
  • 7.8. Market Volume, by Country (2017-2030)
  • 7.9. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Volume, by Type (2017-2030)
  • 8.3. Market Revenue, by Type (2017-2030)
  • 8.4. Market Volume, by Application (2017-2030)
  • 8.5. Market Revenue, by Application (2017-2030)
  • 8.6. Market Volume, by End User (2017-2030)
  • 8.7. Market Revenue, by End User (2017-2030)
  • 8.8. Market Volume, by Country (2017-2030)
  • 8.9. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Volume, by Type (2017-2030)
  • 9.3. Market Revenue, by Type (2017-2030)
  • 9.4. Market Volume, by Application (2017-2030)
  • 9.5. Market Revenue, by Application (2017-2030)
  • 9.6. Market Volume, by End User (2017-2030)
  • 9.7. Market Revenue, by End User (2017-2030)
  • 9.8. Market Volume, by Country (2017-2030)
  • 9.9. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Volume, by Type (2017-2030)
  • 10.3. Market Revenue, by Type (2017-2030)
  • 10.4. Market Volume, by Application (2017-2030)
  • 10.5. Market Revenue, by Application (2017-2030)
  • 10.6. Market Volume, by End User (2017-2030)
  • 10.7. Market Revenue, by End User (2017-2030)
  • 10.8. Market Volume, by Country (2017-2030)
  • 10.9. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Volume, by Type (2017-2030)
  • 11.3. Market Revenue, by Type (2017-2030)
  • 11.4. Market Volume, by Application (2017-2030)
  • 11.5. Market Revenue, by Application (2017-2030)
  • 11.6. Market Volume, by End User (2017-2030)
  • 11.7. Market Revenue, by End User (2017-2030)
  • 11.8. Market Volume, by Country (2017-2030)
  • 11.9. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Volume, by Type (2017-2030)
  • 12.3. Market Revenue, by Type (2017-2030)
  • 12.4. Market Volume, by Application (2017-2030)
  • 12.5. Market Revenue, by Application (2017-2030)
  • 12.6. Market Volume, by End User (2017-2030)
  • 12.7. Market Revenue, by End User (2017-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Volume, by Type (2017-2030)
  • 13.3. Market Revenue, by Type (2017-2030)
  • 13.4. Market Volume, by Application (2017-2030)
  • 13.5. Market Revenue, by Application (2017-2030)
  • 13.6. Market Volume, by End User (2017-2030)
  • 13.7. Market Revenue, by End User (2017-2030)

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Volume, by Type (2017-2030)
  • 14.3. Market Revenue, by Type (2017-2030)
  • 14.4. Market Volume, by Application (2017-2030)
  • 14.5. Market Revenue, by Application (2017-2030)
  • 14.6. Market Volume, by End User (2017-2030)
  • 14.7. Market Revenue, by End User (2017-2030)

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Volume, by Type (2017-2030)
  • 15.3. Market Revenue, by Type (2017-2030)
  • 15.4. Market Volume, by Application (2017-2030)
  • 15.5. Market Revenue, by Application (2017-2030)
  • 15.6. Market Volume, by End User (2017-2030)
  • 15.7. Market Revenue, by End User (2017-2030)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Volume, by Type (2017-2030)
  • 16.3. Market Revenue, by Type (2017-2030)
  • 16.4. Market Volume, by Application (2017-2030)
  • 16.5. Market Revenue, by Application (2017-2030)
  • 16.6. Market Volume, by End User (2017-2030)
  • 16.7. Market Revenue, by End User (2017-2030)

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Volume, by Type (2017-2030)
  • 17.3. Market Revenue, by Type (2017-2030)
  • 17.4. Market Volume, by Application (2017-2030)
  • 17.5. Market Revenue, by Application (2017-2030)
  • 17.6. Market Volume, by End User (2017-2030)
  • 17.7. Market Revenue, by End User (2017-2030)

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Volume, by Type (2017-2030)
  • 18.3. Market Revenue, by Type (2017-2030)
  • 18.4. Market Volume, by Application (2017-2030)
  • 18.5. Market Revenue, by Application (2017-2030)
  • 18.6. Market Volume, by End User (2017-2030)
  • 18.7. Market Revenue, by End User (2017-2030)

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Volume, by Type (2017-2030)
  • 19.3. Market Revenue, by Type (2017-2030)
  • 19.4. Market Volume, by Application (2017-2030)
  • 19.5. Market Revenue, by Application (2017-2030)
  • 19.6. Market Volume, by End User (2017-2030)
  • 19.7. Market Revenue, by End User (2017-2030)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Volume, by Type (2017-2030)
  • 20.3. Market Revenue, by Type (2017-2030)
  • 20.4. Market Volume, by Application (2017-2030)
  • 20.5. Market Revenue, by Application (2017-2030)
  • 20.6. Market Volume, by End User (2017-2030)
  • 20.7. Market Revenue, by End User (2017-2030)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Volume, by Type (2017-2030)
  • 21.3. Market Revenue, by Type (2017-2030)
  • 21.4. Market Volume, by Application (2017-2030)
  • 21.5. Market Revenue, by Application (2017-2030)
  • 21.6. Market Volume, by End User (2017-2030)
  • 21.7. Market Revenue, by End User (2017-2030)

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Volume, by Type (2017-2030)
  • 22.3. Market Revenue, by Type (2017-2030)
  • 22.4. Market Volume, by Application (2017-2030)
  • 22.5. Market Revenue, by Application (2017-2030)
  • 22.6. Market Volume, by End User (2017-2030)
  • 22.7. Market Revenue, by End User (2017-2030)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Volume, by Type (2017-2030)
  • 23.3. Market Revenue, by Type (2017-2030)
  • 23.4. Market Volume, by Application (2017-2030)
  • 23.5. Market Revenue, by Application (2017-2030)
  • 23.6. Market Volume, by End User (2017-2030)
  • 23.7. Market Revenue, by End User (2017-2030)

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Volume, by Type (2017-2030)
  • 24.3. Market Revenue, by Type (2017-2030)
  • 24.4. Market Volume, by Application (2017-2030)
  • 24.5. Market Revenue, by Application (2017-2030)
  • 24.6. Market Volume, by End User (2017-2030)
  • 24.7. Market Revenue, by End User (2017-2030)

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Volume, by Type (2017-2030)
  • 25.3. Market Revenue, by Type (2017-2030)
  • 25.4. Market Volume, by Application (2017-2030)
  • 25.5. Market Revenue, by Application (2017-2030)
  • 25.6. Market Volume, by End User (2017-2030)
  • 25.7. Market Revenue, by End User (2017-2030)

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Volume, by Type (2017-2030)
  • 26.3. Market Revenue, by Type (2017-2030)
  • 26.4. Market Volume, by Application (2017-2030)
  • 26.5. Market Revenue, by Application (2017-2030)
  • 26.6. Market Volume, by End User (2017-2030)
  • 26.7. Market Revenue, by End User (2017-2030)

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Volume, by Type (2017-2030)
  • 27.3. Market Revenue, by Type (2017-2030)
  • 27.4. Market Volume, by Application (2017-2030)
  • 27.5. Market Revenue, by Application (2017-2030)
  • 27.6. Market Volume, by End User (2017-2030)
  • 27.7. Market Revenue, by End User (2017-2030)

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Volume, by Type (2017-2030)
  • 28.3. Market Revenue, by Type (2017-2030)
  • 28.4. Market Volume, by Application (2017-2030)
  • 28.5. Market Revenue, by Application (2017-2030)
  • 28.6. Market Volume, by End User (2017-2030)
  • 28.7. Market Revenue, by End User (2017-2030)

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. Johnson & Johnson Services Inc.
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. ARKRAY Inc.
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. Nova Biomedical
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. Bionime Corporation
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
  • 30.5. Medtronic plc
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. B. Braun Melsungen AG
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. Abbott Laboratories
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary
  • 30.8. Bayer AG
    • 30.8.1. Business overview
    • 30.8.2. Product and service offerings
    • 30.8.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports